Please try another search
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, soft contact lens, medical sodium hyaluronate gels, injectors, scalpels, suture needles, and other products; orthopedics products, such as sodium hyaluronate injection and medical chitosan products; and anti-adhesion products, including medical sodium hyaluronate gel, and medical chitosan and collagen sponge products. The company also provides medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; recombinant human epidermal growth factor products; and radio frequency devices and laser equipment. In addition, it is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Zhi Su | 44 | 2020 | Independent Non-Executive Director |
Lei Zhao | 47 | 2020 | Independent Non-Executive Director |
Jianying Wu | 57 | 2010 | GM & Executive Director |
Yuanzhong Liu | 52 | 2010 | Chairman of the Supervisory Committee |
Minjie Tang | 46 | 2016 | CFO & Executive Director |
Yongtai Hou | 59 | 2010 | Executive Chairman |
Yiyi Chen | 39 | 2010 | Executive Director |
Jie You | 60 | 2010 | Non Executive Director |
Ming Ping Huang | 47 | 2010 | Non-Executive Director |
Hongbo Shen | 45 | 2024 | Independent Non-Executive Director |
Yuejun Tang | 45 | 2014 | Independent Supervisor |
Zhihong Jiang | 54 | 2020 | Independent Non-Executive Director |
Qing Yang | 52 | 2014 | Independent Supervisor |
Changzheng Wei | 44 | 2010 | Employee Representative Supervisor |
Xiao Song | 41 | 2022 | Staff Representative Supervisor |
Yushe Yang | 60 | 2020 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review